adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable…

Overview of attention for article published in Journal of Clinical Oncology, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 11 news outlets

twitter: 5 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,290 followers.

@andrewpannu Cool work, add this to your list. A p2 nci trial reads out early 2025. https://t.co/qwpcAJMZbe

RT @JohnEbbenMDPhD: @AnwaarSaeed3 @rprobinpark @TumorBoardTues @MPishvaian @FightCRC @Dr_Ivanoncologo @CathyEngMD @jonathanloree @OncoThor…

@AnwaarSaeed3 @rprobinpark @TumorBoardTues @MPishvaian @FightCRC @Dr_Ivanoncologo @CathyEngMD @jonathanloree @OncoThor @GIcancerDoc @skopetz @erikamartin3lli @adasarimd @DrPipDunne @JamesClearyMD @manjuggm @ronanhsieh @DrKatePedersen @FASinicropeMD @smi…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.